Precision medicine
Also: Rupa Health raised $20 million for its lab test platform, and CancerIQ scooped up $14 million in Series B funding.
The clinical trial results will be used to expand Viome’s mRNA platform, which in May received FDA breakthrough device designation for identifying early signs of oral and throat cancers.
The industrial giant plans to retain a stake of almost 20% in GE Healthcare.
The partnership will initially be used to distribute PathAI’s research-use-only algorithm focusing on immuno-oncology.
IntelliSite is designed to streamline workflows, enhance diagnostic confidence, facilitate collaboration, integrate AI and increase the efficiency of pathology labs.
The SoftVue system is intended to be used in addition to digital mammograms to screen for cancer among patients with dense breast tissue.
The ANT-X system helps clinicians perform safe and accurate percutaneous needle placement.
Paige Prostate analyzes digitized biopsy slides and identifies areas that could be cancerous for the pathologist to review further.
The data collected will be added to an open repository that other researchers can use to study the impact of spaceflight on the human body.
Itamar Medical plans to provide additional information on its product improvements at the Virtual SLEEP 2021 Conference.